Yuemei Hu

4.7k total citations
71 papers, 1.3k citations indexed

About

Yuemei Hu is a scholar working on Epidemiology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yuemei Hu has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 23 papers in Infectious Diseases and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yuemei Hu's work include Respiratory viral infections research (18 papers), Hepatitis B Virus Studies (16 papers) and Viral gastroenteritis research and epidemiology (16 papers). Yuemei Hu is often cited by papers focused on Respiratory viral infections research (18 papers), Hepatitis B Virus Studies (16 papers) and Viral gastroenteritis research and epidemiology (16 papers). Yuemei Hu collaborates with scholars based in China, United States and Taiwan. Yuemei Hu's co-authors include Fengcai Zhu, Jingxin Li, Kai Chu, Qi Liang, Fanyue Meng, Xiaochun Yin, Zengguang Liu, Shipo Wu, Wei Chen and Jing Yang and has published in prestigious journals such as The Lancet, The Journal of Infectious Diseases and International Journal of Cancer.

In The Last Decade

Yuemei Hu

68 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuemei Hu China 21 601 418 255 228 141 71 1.3k
Wanhong Xu Canada 21 652 1.1× 590 1.4× 264 1.0× 358 1.6× 167 1.2× 63 1.9k
Xiaobo Wang China 24 833 1.4× 252 0.6× 144 0.6× 291 1.3× 129 0.9× 78 1.6k
Andrew Turner United Kingdom 24 367 0.6× 1.1k 2.7× 67 0.3× 134 0.6× 53 0.4× 80 2.1k
Sakthivel Subramaniam United States 21 652 1.1× 90 0.2× 114 0.4× 98 0.4× 86 0.6× 82 1.2k
Chiyu Zhang China 31 1.6k 2.6× 876 2.1× 236 0.9× 843 3.7× 30 0.2× 187 3.3k
Yifeng Jiang China 20 727 1.2× 198 0.5× 122 0.5× 112 0.5× 18 0.1× 73 1.3k
Robert Brownlie Canada 21 334 0.6× 441 1.1× 39 0.2× 356 1.6× 17 0.1× 48 1.6k
Mingshu Wang China 26 633 1.1× 727 1.7× 666 2.6× 443 1.9× 10 0.1× 167 2.2k
Benjamin Morin United States 15 451 0.8× 373 0.9× 76 0.3× 246 1.1× 61 0.4× 35 1.1k
Ying Fang China 24 185 0.3× 271 0.6× 53 0.2× 744 3.3× 19 0.1× 86 1.8k

Countries citing papers authored by Yuemei Hu

Since Specialization
Citations

This map shows the geographic impact of Yuemei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuemei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuemei Hu more than expected).

Fields of papers citing papers by Yuemei Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuemei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuemei Hu. The network helps show where Yuemei Hu may publish in the future.

Co-authorship network of co-authors of Yuemei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuemei Hu. A scholar is included among the top collaborators of Yuemei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuemei Hu. Yuemei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Kai, Yuemei Hu, Hongxing Pan, et al.. (2023). A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age. Human Vaccines & Immunotherapeutics. 19(2). 2235926–2235926. 2 indexed citations
2.
3.
Tang, Rong, et al.. (2020). The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines. BMC Infectious Diseases. 20(1). 641–641. 3 indexed citations
4.
Li, Juan, Zhijie Lin, Hui Zhao, et al.. (2020). Immunogenicity of an Escherichia coli -produced bivalent human papillomavirus vaccine under different vaccination intervals. Human Vaccines & Immunotherapeutics. 16(7). 1630–1635. 2 indexed citations
5.
Zhu, Jia-Hong, Xiaohong Wu, Yuhua Li, Fengcai Zhu, & Yuemei Hu. (2018). Investigation on the effects of booster immunization of human diploid cell rabies vaccine after eight years of primary vaccination. 32(3). 233–236. 1 indexed citations
6.
Chu, Kai, Ling Wang, Yuansheng Hu, et al.. (2018). Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: A phase II, randomized, dose-finding trial. Vaccine. 36(45). 6782–6789. 20 indexed citations
7.
Hong, Tao, Yuemei Hu, Xing Wu, et al.. (2017). A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine. Vaccine. 35(37). 5073–5080. 40 indexed citations
8.
Wei, Mingwei, Fanyue Meng, Shiyuan Wang, et al.. (2016). 2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study. The Journal of Infectious Diseases. 215(1). 56–63. 51 indexed citations
9.
Liu, Wenyu, Feixue Wei, Jie Tang, et al.. (2016). [Detection of neutralizing antibodies and DNA of human papillomavirus 16, 18 in women aged 18-45 years in Funing, Jiangsu province].. PubMed. 37(3). 406–9. 1 indexed citations
10.
11.
Zhu, Fengcai, Yuemei Hu, Jingxin Li, et al.. (2016). Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Compared With 7-valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China. The Pediatric Infectious Disease Journal. 35(9). 999–1010. 8 indexed citations
12.
13.
Li, Jingxin, et al.. (2015). [Epidemiological characteristics of enterovirus type 71 diseases].. PubMed. 36(1). 45–8. 1 indexed citations
14.
15.
16.
Wang, Shenyu, Zhenglun Liang, Xiuling Li, et al.. (2014). A Booster Dose of an Inactivated Enterovirus 71 Vaccine in Chinese Young Children: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. The Journal of Infectious Diseases. 210(7). 1073–1082. 15 indexed citations
17.
Tao, Kun, et al.. (2013). Comparative study of the cervista and hybrid capture 2 methods in detecting high‐risk human papillomavirus in cervical lesions. Diagnostic Cytopathology. 42(3). 213–217. 10 indexed citations
18.
Hu, Yuemei, Shoujie Huang, Kai Chu, et al.. (2013). Safety of anEscherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine. Human Vaccines & Immunotherapeutics. 10(2). 469–475. 27 indexed citations
19.
Hu, Yuemei, et al.. (2007). Design of Multi-signature Scheme in Wireless Networks. 42. 247–251. 4 indexed citations
20.
Hu, Yuemei, et al.. (2000). Safety and immunogenicity of lyophilized, live attenuated hepatitis A vaccine in non-human primate model.. PubMed. 113(4). 332–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wanhong Xu Breakdown of academic impact, for papers by Xiaobo Wang Breakdown of academic impact, for papers by Andrew Turner Breakdown of academic impact, for papers by Sakthivel Subramaniam Breakdown of academic impact, for papers by Chiyu Zhang Breakdown of academic impact, for papers by Yifeng Jiang Breakdown of academic impact, for papers by Robert Brownlie Breakdown of academic impact, for papers by Mingshu Wang Breakdown of academic impact, for papers by Benjamin Morin Breakdown of academic impact, for papers by Ying Fang
Rankless by CCL
2026